Robert Blasberg, MD
Ophthalmology · Sandy Springs, GANPI 1922005487
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,418 of the $14,278 with a category attached, or 80.0%. 29 manufacturers reported payments, led by Alcon at 35.7% of the total. Among ophthalmology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 199 payments — averaging $71.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$5K
- Johnson & Johnson Surgical Vision, Inc.$3K
- Carl Zeiss Meditec USA, Inc.$945
- Glaukos Corporation$777
- AbbVie$687
- Carl Zeiss Meditec, Inc.$504
- plus $3K from 23 others
Across 10 payments — averaging $4461.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$45K
What the payments were for
- Travel & lodging$1,43010%
- Food & beverage$11,41880%
- Education$5004%
- Other$9307%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 58 | $5,090 |
| Johnson & Johnson Surgical Vision, Inc. | 51 | $2,824 |
| Carl Zeiss Meditec USA, Inc. | 2 | $945 |
| Glaukos Corporation | 8 | $777 |
| AbbVie(2 entities) | 18 | $687 |
| Carl Zeiss Meditec, Inc. | 5 | $504 |
| Coopervision Inc. | 2 | $500 |
| Eyepoint US, Inc. | 3 | $378 |
| Aerie Pharmaceuticals, Inc. | 6 | $312 |
| NEW World Medical,inc. | 3 | $304 |
| Sight Sciences, Inc. | 7 | $285 |
| Eyevance Pharmaceuticals LLC | 1 | $172 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $171 |
| Shire North American Group Inc | 2 | $143 |
| Sun Pharmaceutical Industries Inc. | 2 | $133 |
| Alimera Sciences, Inc. | 1 | $127 |
| Kala Pharmaceuticals, Inc. | 2 | $126 |
| Biotissue Holdings Inc. | 2 | $117 |
| Rxsight Inc | 4 | $106 |
| Astellas Pharma US Inc | 1 | $105 |
| Bausch & Lomb Americas Inc. | 1 | $105 |
| Apellis Pharmaceuticals, Inc. | 1 | $103 |
| Novartis | 5 | $86 |
| Amgen(2 entities) | 4 | $80 |
| Oyster Point Pharma, Inc. | 1 | $24 |
| Tarsus Pharmaceuticals, Inc. | 1 | $22 |
| Ocular Therapeutix, Inc. | 1 | $20 |
| Harrow Eye, LLC | 1 | $19 |
| Dompe US, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LenSx$1,103
- LUMERA 700$930
- Tecnis IOL$824
- Clareon$593
- MiSight Contact Lens$500
- Rhopressa$365
- Rocklatan$365
- DURYSTA$340
- AcrySof IQ PanOptix$288
- Clareon PanOptix Pro$252
- DEXYCU$250
- Tecnis Symfony IOL$239
- AcrySof IQ PanOptix UV IOL$186
- Tobradex ST$172
- AcrySof IQ VIVITY IOL$150
- OMNI(R) SURGICAL SYSTEM (US)$147
- PanOptix$143
- NGENUITY$137
- OPMI Lumera$134
- YUTIQ$128
How this compares
$14,278 in reported general payments places this provider in the 90th percentile of 481 ophthalmology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RocklatanNetarsudil Mesylat/Latanoprost | 44 | $26,773 |
| RestasisCyclosporine | 24 | $24,943 |
| MieboPerfluorohexyloctane/Pf | 16 | $13,478 |
| CombiganBrimonidine Tartrate/Timolol | 35 | $11,461 |
| LumiganBimatoprost | 15 | $10,260 |
| Latanoprost | 654 | $7,951 |
| Cyclosporine | 14 | $7,723 |
| RhopressaNetarsudil Mesylate | 12 | $6,268 |
| Travoprost | 36 | $5,943 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 117 | $5,330 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 279 | $5,213 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 20 | $5,114 |
| ProlensaBromfenac Sodium | 14 | $4,895 |
| Loteprednol Etabonate | 17 | $3,815 |
| Brimonidine Tartrate | 29 | $3,505 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Combigan, Lumigan | $687 | $46,66374 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $312 | $33,04156 claims |
| Bausch & Lomb Americas Inc.Miebo | $105 | $13,47816 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa, Loteprednol Etabonate, Lotemax Sm | $171 | $11,56942 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 481 ophthalmology providers in Georgia.
Other ophthalmology in Sandy Springs
- Dana WallaceSandy Springs$27K
- Jessica McCluskeySandy Springs$23K
- Gagan SawhneyAtlanta$582K
- Lawrence WoodardAtlanta$578K
- Stephanie VanderveldtAtlanta$384K
- Steven YehAtlanta$289K
- Jack ChapmanGainesville$244K
- Gregory LeeCumming$214K
- Puneet PandaMarietta$185K
- Jeffrey TranSuwanee$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.